Pallas Health vs Telos Rx: Compounded GLP-1 options & pricing
The Pallas Health vs Telos Rx comparison boils down to clinician-reviewed access to compounded GLP-1s and how each service prices and delivers care. Quick verdict: Telos Rx advertises lower starting monthly pricing for compounded semaglutide as low as $99 per month, while Pallas Health emphasizes a single intake that can yield either FDA-approved brand pens or clinician-personalized compounded semaglutide starting at $139 for the first month then $199 per month on average.
View Pallas Health options and details
How they compare at a glance
This comparison uses only the supplied facts: both providers offer clinician-reviewed online prescribing of GLP-1 compounds; both note that compounded medications are not FDA-approved. The most distinctive differences are pricing structure and brand versus compound pathways, scope of online care and visit requirements, renewal and billing cadence, and explicit pricing disclosures.
Direct differences we use below
- Pricing and starting cost: Telos Rx lists semaglutide as low as $99 per month; Pallas shows compounded semaglutide $139 first month, then $199/mo average.
- Brand-name access: Pallas offers FDA-approved Wegovy, Ozempic, Zepbound and Mounjaro as options chosen by a clinician; Telos Rx captures only compounded semaglutide and tirzepatide in the supplied evidence.
- Plan scope and fees: Pallas states one all-in plan price with provider care, check-ins and messaging included and no membership fee; Telos Rx materials emphasize compounded medications prescribed online with pricing subject to approval.
- Renewal cadence and pricing presentation: Pallas compounds renew every 12 weeks at specified amounts that translate to monthly averages; Telos Rx frames per-month pricing as low as figures and notes price depends on plan and approval.
Side-by-side comparison table
| Criteria | Pallas Health | Telos Rx |
|---|---|---|
| Starting price (compounded semaglutide) | $139 first month, then $597 every 12 weeks ($199/mo avg) | Semaglutide as low as $99 per month |
| Compounded tirzepatide pricing | $179 first month, then $897 every 12 weeks ($299/mo avg) | Tirzepatide as low as $139 per month when approved |
| Brand-name medication availability | FDA-approved Wegovy, Ozempic, Zepbound and Mounjaro available if clinician selects | Captured evidence references compounded semaglutide and tirzepatide only |
| Care and plan inclusions | One all-in plan price includes clinician review, ongoing check-ins and messaging; no membership fee | Compounded medications prescribed online by a US-licensed provider; pricing and eligibility subject to approval |
| Billing and renewal notes | Compounded plans renew every 12 weeks at listed amounts; intro month pricing is lower | Pricing framed per month and noted to depend on plan and approval; cancel anytime noted |
| Regulatory note | Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality | Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality |
Pricing structure and transparency
Pallas Health provides explicit figures for compounded plans: semaglutide $139 first month then $597 per 12 weeks (a $199 per month average) and tirzepatide $179 first month then $897 per 12 weeks (a $299 per month average). It also lists cash-pay brand pen prices for Wegovy, Zepbound, Ozempic and Mounjaro. Telos Rx presents “as low as” monthly figures and notes that your price depends on your plan and medical approval, with semaglutide as low as $99 per month and tirzepatide as low as $139 per month in the captured evidence.
Check Telos Rx pricing and eligibility
Care model and program inclusions
Pallas frames a single intake that can lead to either FDA-approved brand pens or clinician-personalized compounded medications. It states clinician review and ongoing check-ins, provider messaging and free expedited shipping are included in plan pricing, and there is no membership fee. Telos Rx materials emphasize that a US-licensed provider decides which medication is right and that treatment is available only when a licensed clinician determines it is medically appropriate. Telos Rx notes cancel anytime language and that pricing and eligibility are subject to approval.
Renewals, cancellation and practical notes
Pallas specifies compounded plans renew every 12 weeks, which affects cancellation timing, and notes that care-team hours are weekdays 9 AM to 5 PM ET with no emergency services. Telos Rx notes cancel anytime with no penalties in the captured evidence and that your price depends on plan and approval. Both vendors include the regulatory qualifier that compounded medications are not FDA-approved.
See Pallas Health clinician-reviewed plans
What this means for you
If your priority is a lower advertised monthly starting price for compounded semaglutide, Telos Rx presents semaglutide as low as $99 per month in the captured evidence. If you want an intake that can result in either FDA-approved brand pens or a clinician-personalized compounded option with provider care bundled and clearly stated 12-week renewal amounts, Pallas Health documents that pathway and pricing, including $139 first month for compounded semaglutide then $199 per month on average.
Review Pallas Health plans and terms
Conclusion and pick guidance
In short, Pallas Health vs Telos Rx differs mainly on advertised starting price and whether brand-name pens are part of the intake options. Both require review by a US-licensed clinician and both include the regulatory note that compounded medications are not FDA-approved.
Choose Pallas Health if you want clinician access to FDA-approved brand pens as well as compounded options, a single all-in plan price with provider care and explicit 12-week renewal pricing for compounded plans. Choose Telos Rx if your primary consideration is the captured lower starting monthly price for compounded semaglutide with per-month pricing framed as low as $99 and plan-dependent approval.